Nitric oxide (NO) is now recognized as an important modulator of an enormous number of physiological processes, ranging from blood pressure regulation to neuronal transmission to penile erectile function. In the gastrointestinal tract, NO also participates in many physiological and pathophysiological processes. In this review, we summarize the contribution made by NO to the ability of the gastrointestinal mucosa to resist injury induced by luminal toxins and to defend against microbial invasion. We also review some of the main features of NO chemistry and the potential of NO as a target for new drugs to treat gastrointestinal disorders.
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A lfred Nobel did pioneering work on the manufacture and use of nitroglycerin as an explosive, culminating in his discovery of dynamite. In addition to its explosive properties, nitroglycerin is the prototypical nitrosovasodilator, still widely used for treatment of angina. Of course, Alfred Nobel has another legacy besides dynamite. Just over a hundred years after his death, the Nobel Prize in Physiology/Medicine was presented to Drs. Robert Furchgott, Ferid Murad, and Louis Ignarro, in part for the demonstration that nitric oxide (NO) was the molecule generated from nitroglycerin that mediated its vasodilatory effects. The discovery of NO, previously termed "endothelial-derived relaxing factor," led to an explosion of research into the biological significance of this molecule, with more than 30,000 publications on the topic of NO in the past 30 years.
What Is NO and How Does It Work?
The discovery that NO is synthesized by mammalian cells has opened a new world of investigation and understanding of homeostatic regulatory systems. Fundamental to this revolution is the discovery that NO mediates its effects not because it binds to specific receptors in a stereochemically specific manner, but rather, reactivity is determined by its electrochemical nature. Despite being a free radical, NO is highly diffusible (approximately 9 times more lipid soluble than water soluble) and rapidly equilibrates between air and solutions. Often we think of free radicals as being highly reactive, toxic species, but this is not the case with NO. In fact, its reactivity is quite limited (Figure 1 ). In a physiological setting, NO reacts with (1) other radicals (a process of annihilation of the free radical state as the electrons pair up), (2) oxygen, and (3) transition metals, such as iron. The latter is the basis for its ability to activate soluble guanylyl cyclase, in which NO interacts with the heme group, facilitating the generation of guanosine 3Ј,5Ј-cyclic monophoshate (cGMP), which in turn mediates many of the biological actions of NO. When NO reacts with hemoglobin, binding to the iron group facilitates the rapid degradation of NO. Because it is very difficult to measure NO levels in biological fluids, one usually measures the oxidative inactivation of NO as either nitrite (NO 2 Ϫ ) or nitrate (NO 3 Ϫ ). Nitrate is stable but nitrite can be reactive, especially under acidic conditions in which it is converted back to N 2 O 3 (the basis of the Griess reaction), as well as reactive with myeloperoxidase (addition of NO 2 ϩ ) to form an excellent nitrating species.
The interaction between NO and oxygen results in a far more complicated series of events, with diverse consequences. The first product of the reaction of NO and oxygen is NO 2 , which rapidly consumes more NO to form N 2 O 3 . These are the same molecules that constitute the brown components of smog. Like smog, they can mediate cell dysfunction and inflammation. However, N 2 O 3 is an excellent nitrosating agent, which at low and regulated levels may actually be a critical component of homeostasis. Nitrosation is the addition of NO ϩ (nitrosonium), with thiol (-SH) groups being the favorite target. Amines, including those in DNA, can also be nitrosated to form nitrosamines, and this may lead to direct point mutations or to the generation of carcinogens. On the other hand, nitrosothiols often mediate biological responses in a manner similar to NO itself. The intracellular localization of nitrosation is likely membranes. Because both NO and oxygen are lipophilic, the rate of their reaction is accelerated 300 times in lipid environments. Thus, thiol-containing transmembrane proteins may well be critical targets for this reaction. However, very little is known about this regulatory process.
The process of NO reacting with other radicals can lead to beneficial effects and deleterious consequences. Generally, in states of high oxidative stress (e.g., ischemia-reperfusion injury), oxygen-derived free radicals will promote lipid peroxidation. This process is self-propagatory and causes havoc in cell function as radical lipid peroxides zip around the membrane. NO, as a lipophilic free radical, terminates this propagation by acting as an antioxidant. The affinity of NO for transition metals can also explain its antioxidant actions in states of oxidative stress. Highly reactive oxygen free radicals such as OH • are catalyzed by interactions with transition metals, and by occupying metal binding sites (a reaction called nitrosylation). NO can prevent this reaction and thereby act as an antioxidant. 1 NO can even extinguish the toxic levels of the by-products of lipid peroxidation. Peroxynitrite (ONOO Ϫ ), which is formed from the interaction of NO and superoxide (O 2 Ϫ ), has a number of deleterious effects as an oxidant, peroxidant, and as a nitrating and nitrosating species, 2,3 but in the presence of excess NO, peroxynitrite is consumed. 4 Thus, it is often difficult to distinguish the effects of NO from its reactive by-products. One could consider NO and its family of reactive nitrogen species as a family of colorful characters. The family reputation may be determined at any given moment as whether the matriarch is in control or whether a naughty nephew has run amok. Similar issues occur with reactive oxygen species and their matriarch, superoxide. Both NO and superoxide are free radicals, but not necessarily reactive or damaging radicals. However, their oxidative by-products may be quite harmful. Here we have a molecular case of "when good parents have bad children."
Cellular Sources of NO
Under normal conditions the enzymatic sources of NO in the gut are limited to what are called the constitutive forms of NO synthase (NOS): endothelial NOS (eNOS, type III) and neuronal NOS (nNOS, type I). As their nomenclature suggests, these two isoforms are found primarily in endothelial cells and neurons, respectively. For the latter, nNOS-containing nerves make up about 50% of the enteric nervous system, a figure that greatly exceeds the number of nNOS nerves in the central nervous system. These isoforms are primarily regulated by levels of intracellular calcium, via calmodulin, and release bursts of NO in response to calcium fluxes. This nomenclature, like all systems aimed at simplification, has exceptions. Neuronal NOS can also be found in epithelia, and eNOS is present in muscle, for example at the lower esophageal sphincter. 5 The other isoform of NOS is referred to as inducible NOS (iNOS, type II), which is calcium/calmodulin independent (activated calmodulin is inserted at the time of synthesis); once iNOS has been formed, activity is determined solely by availability of substrate and cofactors. The induction of iNOS usually occurs in states of inflammation and immune activation. The primary cell types expressing iNOS are macrophages and neutrophils. However, with strong signals for induction, epithelial cells can also express iNOS, as is the case in experimental colitis. 6, 7 By contrast, in milder states of inflammation such as gastritis, iNOS is found solely in infiltrating immune cells. 8 In experimental models of inflammation, iNOS has also been identified in neurons 6 : the potential importance of this is still being addressed.
Two Faces of NO
Just as nitroglycerin has diverse uses that range from very destructive to the assuagement of pain, the effects of NO in the gastrointestinal tract, and in other tissues, are widespread and somewhat enigmatic. NO undoubtedly contributes to the modulation of several key physiological functions in the digestive system, but it has also been suggested to be a critical mediator of tissue injury in several intestinal disorders. This paradox can be explained, at least to some extent, by the ability of different concentrations of NO to produce completely opposite effects in the same tissue. Thus, if NO is produced in small amounts, it generally exerts beneficial effects in the gastrointestinal tract, whereas production of high amounts of NO can be detrimental. In general, the neuronal and endothelial forms of NOS produce the low amounts of NO that perform many physiological functions. In contrast, the inducible form of NOS produces much higher concentrations of NO and appears to participate in a number of pathophysiological processes. Actions of NO derived from nNOS and eNOS are generally simpler, usually involving interactions with heme groups, such as soluble guanylyl cyclase. Antioxidant actions in acute events such as ischemia-reperfusion are also mediated by NO from these constitutive isoforms. On the other hand, iNOS-derived NO leads to a host of responses mediated by a range of nitrogen oxides.
NO in Mucosal Defense
The gastrointestinal tract shows a remarkable resilience to damage induced by foodstuffs with a wide range of osmolarity, pH, and temperature; detergent actions of bile; proteolytic actions of several gastric, intestinal, and pancreatic secretions; and potentially harmful actions of enteric microbes. 9 NO plays a critical role in modulating several components of mucosal defense, as outlined in more detail in Figure 2 .
Mucus and Fluid Secretion
Mucus contributes to mucosal defense by providing a physical barrier to bacteria, thereby reducing bacterial adherence to the epithelium and invasion of the mucosa. Mucus also acts as a lubricant to reduce physical abrasion of the mucosa and participates in the protection of the mucosa from damage induced by acid and other luminal toxins. An increase in mucus thickness is a normal defensive response to luminal insult. Brown et al. 10 showed that NO is an important regulator of mucus secretion in the stomach, and that its effects are produced via stimulation of guanylyl cyclase in the epithelial cell. NO also mediates the increase in gastric mucus release observed after stimulation with carbachol. 11 Thus, NO appears to be produced within the epithelial cell in response to activation of cholinergic receptors, and to trigger the release of mucus from those cells.
A second mechanism through which the gastrointestinal epithelium defends itself against bacterial invasion is through the secretion of fluid into the lumen. As well as reducing bacterial adherence, the secretion of fluid dilutes and flushes away any potentially noxious substances in the lumen. In general, fluid secretion across the gastrointestinal epithelium is osmotically driven by the active transport of chloride ions into the lumen. This process can be regulated by numerous soluble mediators and neurotransmitters. 12 NO seems to play an important role in modulating epithelial fluid secretion. NO donors have been shown to stimulate chloride transport in the small intestine, 13, 14 and NO has been suggested to be involved in cholera toxin-induced intestinal secretion 15 and duodenal bicarbonate secretion. 16 Paradoxically, in some circumstances, NO seems to exert inhibitory effects on intestinal secretion. This may depend on the concentration of NO that is produced: low amounts of NO are stimulatory but high amounts are inhibitory. Epithelial secretion has been shown to be impaired during 17 and for a long time after 18 a bout of colitis in rodents; this was mediated by iNOS-derived NO. 17, 18 Epithelial Barrier
If microbes are able to penetrate through the mucus and fluid secreted by the epithelium, the next barrier they encounter is the tight junction between adjacent epithelial cells. Epithelial barrier function is often measured using permeability markers. With this type of approach in cultured epithelial cells, NO has been shown to regulate epithelial barrier function. Exposure of these cells to NO donors results in a significant increase in permeability. 19 Also, cytokines such as interferon (IFN)-␥ have been shown to increase epithelial permeability, and its effects are mediated via NO. That is, inhibitors of NOS prevent the increase in epithelial permeability induced by IFN-␥. 20 IFN-␥ also increases the expression of iNOS in the epithelium. The mechanism of action of NO in altering epithelial permeability is not known. However, because NO has a well-characterized ability to relax smooth muscle, it is possible that similar effects on contractile proteins within the epithelial cells that regulate the intercellular tight junctions account for its effects on permeability.
Epithelial permeability can also be regulated by NO in an indirect manner. Kanwar et al. 21 showed that administration of an inhibitor of NOS resulted in significant increases in intestinal permeability in the rat. The increase in permeability could be blocked by combined antagonism of histamine H 1 and platelet-activating factor (PAF) receptors, or by administration of mast cell stabilizers. Kanwar et al. 21 showed that the inhibitor of NOS caused degranulation of mast cells. They proposed that histamine and PAF were released from the degranulating mast cells, and that these agents then produced the alterations in epithelial barrier function. The ability of NO to alter mast cell reactivity is discussed in more detail below.
Of note, there is evidence of functional consequences of the effects of NO on epithelial barrier function. Rats treated with inhibitors of NOS and iNOS-deficient had reduced levels of bacterial translocation, [21] [22] [23] [24] consistent with the notion that NO can increase permeability.
Microcirculation
NO is an important mediator of vascular tone in the gastrointestinal tract, as it is elsewhere in the body.
Various agents, such as acetylcholine, bradykinin, and histamine, can stimulate the generation of NO by the vascular endothelium. The NO that diffuses into the blood vessel is rapidly inactivated (half-life, approximately 6 seconds), primarily through an interaction with oxyhemoglobin. 25 The half-life of NO can be extended significantly by superoxide dismutase, indicating that NO is also inactivated through an interaction with superoxide anion. 26 NO also diffuses across the abluminal endothelial cell membrane and is able to enter the underlying vascular smooth muscle cells where it stimulates soluble guanylyl cyclase. The resulting relaxation of vascular smooth muscle accounts for the vasodilation typically observed with substances that, for many years, have been referred to as endothelium-dependent vasodilators. It was the work of Furchgott, Murad, and Ignarro, [27] [28] [29] together with important contributions by Moncada et al., 26, 30 that resulted in the identification of NO as "endothelium-derived relaxing factor."
Many studies have shown the importance of NO in regulating gastrointestinal blood flow, mainly through the use of inhibitors of NOS. [31] [32] [33] One of the most well-characterized vascular responses in the gastrointestinal tract is the reactive hyperemic response to mucosal injury. When the mucosa is exposed to an irritant, a rapid increase in mucosal blood flow occurs. This response is initiated by sensory afferent nerves underlying the epithelium. 34 In the stomach, these nerves respond to the entry of acid to the lamina propria. Activation of these neurons results in the release of calcitonin generelated peptide (CGRP) in the vicinity of submucosal arterioles. 35 CGRP is one of the endothelium-dependent vasorelaxants. Thus, CGRP interacts with a receptor on the vascular endothelium, leading to activation of eNOS and subsequent production of NO. The NO causes relaxation of the vascular smooth muscle, and as a result of the dilation of submucosal arterioles, mucosal blood flow increases. The increase in blood flow is important: it permits buffering of acid that has entered the lamina propria as well as dilution and removal of any toxins that had crossed the epithelium. The reactive hyperemia is also critical for rapid repair of epithelial damage, through the process of restitution. The importance of the reactive hyperemic response is underscored by the demonstration that ablation of the sensory afferent nerves within the stomach results in a profound increase in the susceptibility of the stomach to damage induced by luminal irritants. 36 Moreover, inhibition of NO synthesis results in elimination of the reactive hyperemic response and to a similar increase in the susceptibility of the stomach to damage. 37 Leukocyte Adherence NO also affects other aspects of the microcirculation besides vascular smooth muscle tone. For example, adherence of leukocytes to the vascular endothelium is influenced by NO. NO has been shown to inhibit expression of the ␤-2 adhesion molecules on neutrophils 38 and P-selectin on the vascular endothelium. 39 Inhibition of NO synthesis results in a marked increase in leukocyte adherence to the endothelium. 40 Adherence of leukocytes to the vascular endothelium in response to stimulation with a chemotactic factor can be suppressed by administration of an NO donor. 41 The adhesion of leukocytes to the endothelium is obviously an important component of the inflammatory response, but in the context of mucosal defense, this process is also important in that leukocyte adherence appears to contribute to the pathogenesis of mucosal injury in a number of settings (e.g., nonsteroidal anti-inflammatory drug [NSAID] gastropathy, ischemiareperfusion injury). [42] [43] [44] [45] Healing
In addition to being very resistant to injury, the gastrointestinal mucosa also exhibits an impressive ability to undergo repair. NO is an important modulator of mucosal repair, probably because of its ability to enhance collagen deposition by fibroblasts and to stimulate angiogenesis. [45] [46] [47] Gastric ulcer healing was retarded by inhibitors of NOS and accelerated by NO donors. 48, 49 Healing of anal fissures in Crohn's disease was accelerated by an NO donor. 50 Considerable work has been done on the role of NO in accelerating wound healing in other tissues, including the demonstration that transfection of a wound in the skin with the gene for iNOS had beneficial effects on healing. 51 Another mechanism through which NO may accelerate wound healing, including gastrointestinal ulcers, is by contributing to the maintenance of blood flow at the margin of the wound. In the stomach, the healing of ulcers depends on proliferation and differentiation of epithelial cells at the ulcer margin. This region receives a high rate of blood flow, and it has been clearly shown that a reduction of blood flow to the ulcer margin results in a retardation of ulcer healing. 52, 53 Mucosal Immune System NO can profoundly influence the function of mesenchymal cells such as fibroblasts and endothelial cells, thereby affecting the ability of the mucosa to resist injury and to undergo repair. NO also has potent effects on immunocytes within the gastrointestinal lamina propria, which again has an impact on the resistance of the mucosa to injury. For example, mast cells are one of the key types of "sentinels" within the lamina propria, releasing numerous chemical signals when appropriately stimulated by exposure to antigens, bacterial products, or various other factors. These chemical signals can play an important role in coordinating an inflammatory response (e.g., release of chemoattractants for various leukocytes) and can alter epithelial permeability. Several chemical mediators that are released by mast cells have been implicated in the pathogenesis of gastrointestinal injury (e.g., leukotrienes, PAF, endothelin, tumor necrosis factor [TNF]). 54 -58 Mast cells have been shown to release NO, via a constitutively expressed NOS. 59 -61 The rate of release of NO from mast cells can be rapidly up-regulated by stimulation with interleukin (IL)-1␤. 61 Interestingly, NO produced by mast cells appears to down-regulate the release of many other inflammatory mediators from these cells, including histamine, PAF, and TNF. 59 -63 As outlined above, inhibition of NO production by mast cells results in an increased propensity of these cells to degranulate; this has been shown to result in significant increases in intestinal epithelial permeability. 21 Mast cell degranulation induced by inhibitors of NO synthesis also results in a marked increase in leukocyte adherence to the vascular endothelium, 64 which can contribute to the generation of mucosal injury.
Effects of NO on the adherence of neutrophils and on their expression of ␤ 2 -integrins was discussed above. NO can also down-regulate neutrophil aggregation and secretion, 65 and may protect the neutrophil from damage induced by the potent reactive oxygen metabolites that it is capable of producing. 66 Thus, as in the case of the mast cell, the overall action of NO could be characterized as anti-inflammatory.
Macrophage function can also be modulated by NO, with important implications for mucosal defense. For example, the production of various immunomodulatory cytokines (e.g., IL-12 and IL-1) can be inhibited by NO. 67, 68 Interestingly, NO can also modulate the actions of macrophage-derived cytokines on target cells. For example, Fiorucci et al. 69 recently showed that administration of aspirin to rats resulted in TNF-dependent apoptosis of cells in the gastric mucosa. They also showed that an NO-releasing aspirin derivative could markedly attenuate the apoptosis, and that this drug could protect gastric chief cells against damage induced by TNF through cGMP-dependent and -independent mechanisms. 69 One of the most important functions of the gastrointestinal macrophage is to kill and remove bacteria that have crossed the epithelium. The ability of macrophages to kill bacteria depends on generation of NO from L-arginine. 70 Evidence from in vitro studies suggests that NO itself is not very toxic to Escherichia coli. 71 However, peroxynitrite formed from the reaction of NO and superoxide anion was found to rapidly kill this bacterium.
Disturbances in NO Biology and Gastrointestinal Disease
Given the numerous roles of NO in mucosal defense and the potential of NO-derived species to be cytotoxic, it is not surprising that NO has been implicated in the pathogenesis of many gastrointestinal diseases. We highlight just two examples.
Inflammatory Bowel Disease
Perhaps the disorder with the most data suggesting a role for NO in its pathogenesis is inflammatory bowel disease (IBD), although most of the data have been derived from experimental models. Both human IBD and experimental models show considerable evidence of greatly increased NO production, 6, 7, 72 most likely as a result of iNOS induction. 6, 7 This occurs not only in infiltrating inflammatory cells but also as a result of expression in epithelial cells, 6, 7 although this latter response is more variable. Increased NO production and iNOS expression can be demonstrated in epithelial cells in vitro in response to activation by bacterial wall fragments and cytokines. 2, 3 The consequences of high amounts of NO in experimental colitis are less clear-cut than in acute forms of gastrointestinal injury. 73 Early studies indicated that inhibition of NO synthesis could prevent gut injury 6, 74 in experimental colitis. With the advent of new models, including mice with specific gene deletions and idiopathic rhesus colitis, it has become clear that this response is not universal. In some cases, no protection was offered by NOS inhibition 75 ; in others the benefits were mild. 76 These inconsistent results in chronic forms of gut inflammation may reflect the complex chemistry and diverse roles played by NO. For example, NO can inhibit transcriptional events by inhibiting the transcription factor NF-B. 77 IBD is characterized by NF-B activation and increased cytokine production. By removing an inhibitory signal from NO (in the face of multiple activating signals), there may be an opportunity for increased cytokine production with NOS inhibitors, a response that may oppose any benefits that arise from reducing levels of nitrogen oxides. Repeated exposure of cells to bacterial endotoxin results in the development of tolerance, characterized by a failure to release cytokines. In the presence of NOS inhibition, endotoxin tolerance is abrogated. 2 Indeed, in idiopathic rhesus colitis, increased production of T-helper cell 1 cytokines ex vivo is evident compared with normal monkeys. However, when challenged with endotoxin, colitic monkeys failed to release more cytokines, whereas endotoxin augmented cytokine release from the colonic mucosa of normal monkeys. This may explain why NOS inhibitors did not offer substantial therapeutic benefit in chronic primate colitis. 75 In terms of NO chemistry, IBD has also been well characterized as a condition in which nitration reactions are evident. Nitrotyrosine is a stable nitration product formed by peroxynitrite and myeloperoxidase-nitritecatalyzed reactions. 3, 6 Nitrotyrosine is absent in normal tissue but evident in many forms of chronic inflammation, and its presence can be blocked by treatment with NOS inhibitors. 6 The functional consequences of nitration reactions are still being determined, but it is certainly a hallmark of disturbances in NO chemistry. Peroxynitrite, the prototypical nitrating species, is highly toxic to mammalian cells and bacteria 3, 71 and likely to be formed as a chemical barrier to bacterial infiltration. Interestingly, 5-aminosalicylic acid (mesalamine), the first line of therapy for IBD, has the ability to prevent epithelial cell death and dysfunction in response to peroxynitrite in the low micromolar range. 78 Thus, mesalamine prevents peroxynitrite-dependent events at doses that are considerably lower than those required for most of the other proposed actions of mesalamine.
Portal Hypertensive Gastropathy
An increased incidence of gastric bleeding is well documented in patients with portal hypertension. 79, 80 Many studies also show disturbances in NO production in patients with portal hypertension and in animal models. 79, 80 These disturbances in NO production may well contribute to the increased susceptibility of the stomach to injury induced by luminal agents. As outlined in detail above, one of the most important components of mucosal defense is the reactive hyperemia that occurs when the gastric mucosa is exposed to an irritant. This NO-mediated vasodilation appears to be impaired in rats with portal hypertension. 81 Indeed, the gastric vasculature exhibits a profound hyporesponsiveness not only to topically applied irritants, but also to NO donors. This hyporesponsiveness results from a defect at the level of the vascular smooth muscle, and is possibly caused by compensatory down-regulation within those cells in response to the very high levels of NO produced in response to portal hypertension. 81 Interestingly, the hyporesponsiveness to NO appears to be partially compensated for by an increased responsiveness of the gastric microcirculation to vasodilatory prostaglandins.
Nitrogen Oxides and Apoptosis
It is well appreciated that numerous disorders of the gastrointestinal tract are associated with the induction of apoptosis, with the epithelial lining as the primary target. NO appears to play an important role in regulating these events and thereby mucosal function; however, the precise role is determined by the redox state of NO. For example, NO can reduce the degree of apoptosis in several conditions, such as anoxia 82 and in response to NSAIDs and TNF-␣. 69, 83 The ability of NO donor moieties to reduce apoptosis during cellular activation has been linked to the inhibition of apoptotic enzymes, such as caspase and IL-1-converting enzyme, through nitrosation of activity-dependent thiol groups. NO itself has been shown to induce endothelial cell apoptosis at high doses 84 ; this is probably caused by conversion of NO to more toxic species such as peroxynitrite or N 2 O 3 . Antioxidants have been shown to protect against peroxynitrite-induced epithelial apoptosis in vitro 78, 85 and in vivo in Helicobacter pylori-associated gastritis. 8 This pattern again highlights the disparate biological activities of NO from its higher oxide forms, but opens the door of therapeutic opportunity to manipulate this process in a favorable manner.
Therapeutic Potential of NO
The therapeutic potential of NO was reviewed in detail recently. 86 Briefly, in situations in which there are greatly increased levels of NO production and a clear indication of a role for NO-derived species in mediating tissue injury (i.e., possibly in IBD), in the future highly selective NOS inhibitors with clinical utility will possibly be available. On the other hand, strong evidence from experimental models shows that NO donors may be useful in enhancing mucosal defense. For example, addition of an NO-releasing moiety to several NSAIDs greatly reduced their toxicity without reducing their efficacy. 87 Other drugs commonly used for treating gastrointestinal disorders, such as mesalamine and prednisolone, have been derivatized in a similar manner; these agents exhibit enhanced anti-inflammatory activity in experimental models. 41, 88 Of course, approaches such as gene therapy (e.g., tranfection with genes for the various NOS isoforms or selective deletion of these genes) may, in the not-too-distant future, become viable options for treating gastrointestinal disorders marked by disturbances in NO biology.
